Novo Holdings, TA Associates agree Biocomposites investment

The transaction gives TA and Novo Holdings shared control of Biocomposites.

3 March 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.